Furthermore, our RNA‐sequencing data demonstrated that 3 of the genes (SCN5A, L1CAM, BMP2) affected with the anti‐ELTD1 treatment that were directly associated with gliomas influenced and interacted with Notch signalling. The gene discussed is ADGRL4; the disease is central nervous system cancer.